Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05124808 · ClinicalTrials.gov registry record · NA

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

A NA study of Overweight and Obesity and Gestational Diabetes, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
828
Enrollment target
5
Study locations

NCT05124808 is a NA study of Overweight and Obesity and Gestational Diabetes that is actively recruiting participants, run by Indiana University. The registered enrollment target is 828 participants, above the 221-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (275% higher). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05124808, a NA study of Overweight and Obesity and Gestational Diabetes, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
828 participants
Enrollment target
5
Study locations

Study Summary

This is a multicenter randomized clinical trial of 828 overweight and obese individuals with gestational diabetes designed to compare standard to intensive glycemic targets.

Interventions

  • OTHER Intensive glycemic targets
  • OTHER Standard glycemic targets

Study Locations (5)

Alabama

  • University of Alabama at Birmingham - Birmingham

Indiana

  • Indiana University - Indianapolis

Oklahoma

  • University of Oklahoma - Norman

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Rhode Island

  • Women and Infants Hospital of Rhode Island - Providence

Trial Details

FieldValue
Enrollment Target 828 participants
Start Date 2022-03-01
Est. Completion 2026-04-08
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT05124808

The ClinicalTrials.gov registry entry for NCT05124808 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 828 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 221-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (275% higher). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which Intensive glycemic targets is the first listed.

NCT05124808 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Alabama, Indiana, Oklahoma.

Frequently Asked Questions

What is clinical trial NCT05124808 about?

NCT05124808 is a clinical study titled "Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes". This is a multicenter randomized clinical trial of 828 overweight and obese individuals with gestational diabetes designed to compare standard to intensive glycemic targets.

What is the current status of trial NCT05124808?

This trial is currently recruiting. It is a NA study. The enrollment target is 828 participants. The study started on 2022-03-01. Estimated completion is 2026-04-08.

What conditions does trial NCT05124808 study?

This clinical trial studies the following conditions: Overweight and Obesity, Gestational Diabetes, Pregnancy, High Risk.

What interventions are being tested in trial NCT05124808?

The interventions under investigation include: Intensive glycemic targets (OTHER), Standard glycemic targets (OTHER).

Who is sponsoring clinical trial NCT05124808?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05124808 being conducted?

This trial has 5 study locations across Alabama, Indiana, Oklahoma, Pennsylvania, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.